FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

analapril

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 18 USDMF, 12 CEP/COS, 4 JDMF, 2 EU WC, 10 KDMF, 10 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

778 FDF Dossiers, 94 FDA Orange Book, 456 Europe, 46 Canada, 34 Australia, 49 South Africa, 99 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET;ORAL - 10MG;25MG, TABLET;ORAL - 5MG;12.5MG, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 5 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 5 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Direct Compression, 25 Granulation, 18 Thickeners and Stabilizers, 18 Lubricants & Glidants, 17 Disintegrants & Superdisintegrants, 16 Controlled & Modified Release, 12 Taste Masking, 10 Co-Processed Excipients, 8 Chewable & Orodispersible Aids, 8 Film Formers & Plasticizers, 6 Rheology Modifiers, 5 Emulsifying Agents, 5 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 3 Coloring Agents, 2 Topical, 1 Solubilizers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 30 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 385 Regulatory FDF Prices

MARKET PLACE

23 APIs, 12 FDF Dossiers

PATENTS & EXCLUSIVITIES

29 US Patents

29 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 JP, 6 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/08/2025	Neuland Laboratories	India	NEULAND LABORATORIES LTD	15434	ENALAPRIL MALEATE	2001-05-15	Active	II	N/A
28/08/2025	Neuland Laboratories	India	NEULAND LABORATORIES LTD	19984	ENALAPRIL MALEATE USP	2006-11-17	Active	II	Complete	2016-06-28	2016-06-16

Analapril

analapril

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers

18 USDMF

12 CEP/COS

4 JDMF

2 EU WC

10 KDMF

10 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

778 FDF Dossiers

94 FDA Orange Book

456 Europe

46 Canada

34 Australia

49 South Africa

99 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 2.5MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET;ORAL - 10MG;25MG

TABLET;ORAL - 5MG;12.5MG

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

5 SPI Pharma

5 DKSH

1 Pharm-RX Chemical

5 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

4 Kirsch Pharma

1 ACG Worldwide

2 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

1 Bioplus Life Sciences

1 CD Formulation

10 Corel Pharma Chem

6 DFE Pharma

6 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

7 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Fillers, Diluents & Binders

41 Coating Systems & Additives

28 Direct Compression

25 Granulation

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons